Deals, Partnering

Ligon Discovery Collaborates with Bayer Schering Pharma to Discover Potential First-in-Class Small Molecule Therapeutics

Posted on 29 September 2010

Tags: ,

Ligon Discovery has partnered with Bayer Schering Pharma to apply its proprietary Small Molecule Microarray screening platform (SMM) to discover potential first-in-class drug candidates for new disease targets see Ligon release at Xconomy

Print Friendly, PDF & Email

Leave a Reply

 

cabannerad300x150new4gif
rauconbadgejpg
e78banner300x150animgif
cpbannerad300x150new2gif
e79banner300x150gif
e78banner300x150animgif